Sector
1063 stories · page 38 of 54
NewLight offers a wide range of pain management services including medical, physiotherapy, chiropractic, massage therapy and acupuncture and orthopedic devices and products that support the lifestyles of those living with chronic pain
KGK Science has successfully helped Hofseth Biocare win New Dietary Ingredient status from the US FDA for its CalGo and OmeGo nutritional supplements extracted from Norwegian Atlantic salmon
The Toronto-based company said that Dr. Nanda brings a wealth of experience and leadership to allied health care in North America and India
The protocols for both studies have received Institutional Review Board approval and patient recruitment is expected to occur in early 2022
The products will consist of a range of both THC and CBD dosages in oral formats
Revitalist Chief Executive Officer Kathryn Walker discusses the company’s growth plans and the advantages of its business model
Irwin Naturals also told investors that its shares have become eligible for delivery and depository services with the Depository Trust Company
The UN’s tourism body has said the tourism sector’s recovery would be “fragile” and “slow”, but the pandemic would cost the global tourism sector $US2 trillion in lost revenue in 2021.
Medicinal use is already legal in many European countries
As one of the first psychedelic companies to go public, the firm’s network of ketamine clinics complements its sharp focus on research and development
The integrated healthcare company reported total revenue for the three and nine months ended September 30, 2021, of $2.7 million and $8.2 million respectively
The company’s Virtual Clinics division has the largest medical cannabis telemedicine network in Canada serving over 50,000 patients
Psychedelic companies feel that Compass Pathways results validate efforts to develop next-generation medicine for treating mental health issues
To date, the company said IRP has successfully performed over 10,000 unique treatments for past or present personnel of the Canadian Armed Forces and the Royal Canadian Mounted Police (RCMP), as well as first responders including firefighte
Analysts were impressed with CareRx's 3Q revenue of C$71.3 million, which beat estimates and led to a series of increased price targets
Through its Bioscience lab, Numinus is the first public company in Canada to receive a licence to produce and extract psilocybin from mushrooms
For the period ended September 30, 2021, the Toronto-based company reported revenue of C$71.3 million, compared to C$45.6 million in the corresponding period a year earlier
KetaMD, currently in beta, is a telemedicine platform in development that aims to provide affordable, potentially life-changing at-home medical ketamine treatments guided by registered nurses
The company also said that it has appointed Director Steven Inglefield as Chief Operating Officer as the company continues to grow its clinic network across Canada and the US
The company expects its Software-as-a-Service (SaaS) revenue for fiscal 2021 to increase by more than 100% year over year